Skip to main content
VulnerabilityPublished Updated

CVE-2026-76154: Grafana OSS · Cross-site Scripting

Affects Grafana OSSSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 7.3 High.

Data as of 1 Nov 2026, 22:58 UTC

CVSS 3.1 base score
7.3High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 28% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 17 Sep 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 1 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
GrafanaGrafana OSSAffected
  • >=12.4.0 <=12.4.10
  • >=13.0.0 <=13.0.8
  • >=13.1.0 <=13.1.5
  • >=13.2.0 <=13.2.1
  • =12.3.0
Fixed in–
GrafanaGrafana EnterpriseAffected
  • >=12.4.0 <=12.4.10
  • >=13.0.0 <=13.0.8
  • >=13.1.0 <=13.1.5
  • >=13.2.0 <=13.2.1
  • =12.3.0
Fixed in–

AI-suggested

In the meantime, restrict Editor role assignments to trusted users and consider limiting access to the Geomap panel until a fix is available.

Description

CVE-2026-76154 is a stored cross-site scripting (XSS) vulnerability in the Geomap panel's MapLibre base layer of Grafana OSS. It allows a user with the Editor role to execute arbitrary JavaScript in another user's session by hosting a malicious style configuration. This can lead to escalation of privileges to Org Admin. The vulnerability affects multiple versions of Grafana OSS, with a CVSS score of 7.3 indicating high severity.

References

Community reviews

Loading reviews…